-
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial2021 The Lancet article Medicine Occupational and environmental lung diseases Open access cited by 4 patents
Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron Scott Mansfield, +13 more
1,233citations -
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study2023 The Lancet article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Jesse Joachim Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson, H. Abdullah-Koolmees, Kathrin Blagec, Tanja Blagus, +92 more
553citations -
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial2020 The Lancet article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip J. Mease, Proton Rahman, Alice Bendix Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie Lillian Xu, +5 more
359citations -
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
Marieke E. Gimbel, Khalid Qaderdan, Laura M. Willemsen, Rik S. Hermanides, Thomas O. Bergmeijer, Evelyn de Vrey, +10 more
357citations -
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses2022 The Lancet article Medicine Respiratory viral infections research Open access cited by 1 patent
Maaike C. Swets, Annemarie Beth Docherty, Nazir Lone, Geert H. Groeneveld, Malcolm Gracie Semple, John Kenneth Baillie
348citations -
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Richard A. Lafayette, Jens Halkjaer Kristensen, Andrew M. Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +6 more
334citations -
Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers, Wouter H. Hinsenveld, Daan Nieboer, Angelique Ceulemans, +56 more
258citations -
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation
Kuniaki Takahashi, Patrick W.J.C. Serruys, Valentı́n Fuster, Michael E. Farkouh, John A. Spertus, David J. Cohen, +10 more
209citations -
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
Doortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk, Yousra J. Dakkak, Leonie E. Burgers, Aleid C. Boer, +10 more
183citations -
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
Andrew Paul Cope, Marianna Jasenecova, Joana Carvalho Vasconcelos, Andrew D. Filer, Karim Raza, Sumera Qureshi, +61 more
182citations -
Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial
Christiaan van der Leij, Bert A. Bonsing, Bas Groot Koerkamp, Vincent Erwin de Meijer, Lois A. Daamen, Stefan A.W. Bouwense, +5 more
179citations -
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial
Wouter van der Steen, Rob A. van de Graaf, Vicky Chalos, Hester Floor Lingsma, Pieter Jan van Doormaal, Jonathan M. Coutinho, +57 more
143citations -
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul A. Deodhar, Filip E Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, Tae‐Hwan Kim, +7 more
142citations